{
  "id": "d40f4e87-a685-4ad0-91b1-5f072e167ae1",
  "answer": "Alnylam Pharmaceuticals, Inc. has a not yet measurable company news read. Its latest completed weekly trend is negative.",
  "status": "insufficient",
  "as_of": "2026-08-16T02:50:36.244956+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "SAO:A1LN34",
    "name": "Alnylam Pharmaceuticals, Inc. (A1LN34)",
    "identity": {
      "sharemaestro_id": "893d4251-3d49-4e3a-af6b-1d7821627ed2",
      "canonical_name": "Alnylam Pharmaceuticals, Inc.",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "A1LN34"
      ],
      "provider_symbols": {
        "eodhd": [
          "A1LN34.SA"
        ],
        "yahoo": "A1LN34.SA",
        "market": "SAO",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Brazil",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 50.0,
  "confidence": 0,
  "evidence_count": 5,
  "independent_sources": 0,
  "freshest_evidence": "2026-08-06T05:49:37.816526+00:00",
  "previous_read": 50.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "A1LN34",
    "company": "Alnylam Pharmaceuticals, Inc.",
    "country": "Brazil",
    "currency": "BRL",
    "exchange": "SAO",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 5,
    "trend_state": "negative",
    "latest_close": "58.919998",
    "score_change": 0.0,
    "weekly_change": 5.933,
    "evidence_status": "insufficient",
    "sentiment_score": 50
  },
  "canonical_url": "https://sharemaestro.com/evidence/d40f4e87-a685-4ad0-91b1-5f072e167ae1/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/893d4251-3d49-4e3a-af6b-1d7821627ed2/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/893d4251-3d49-4e3a-af6b-1d7821627ed2/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=A1LN34"
    }
  ],
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "99b59bf75c93207d96b35224b8057da6828e6a9ebea4ae29939ce17fe79c2d51",
  "citation": "Sharemaestro, Alnylam Pharmaceuticals, Inc. (A1LN34), 2026-08-16, https://sharemaestro.com/evidence/d40f4e87-a685-4ad0-91b1-5f072e167ae1/"
}